mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.0008 |
mRNA |
JNJ-26854165 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0009 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
Bryostatin 1 |
FIMM |
pan-cancer |
AAC |
0.42 |
0.001 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.001 |
mRNA |
BRD-K41334119 |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
0.001 |
mRNA |
XL765 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
austocystin d |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |